SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: S-3, Date: 2013-12-04
Original SEC Filing: Click here


Webplus: SKBI/20131204/S-3_1/1/000.htm SEC Original: v355137_s3.htm
FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei




Webplus: SKBI/20131204/S-3_1/2_EX-4.1/000.htm SEC Original: v355137_ex4-1.htm
SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8




Webplus: SKBI/20131204/S-3_1/3_EX-4.2/000.htm SEC Original: v355137_ex4-2.htm
SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10




Webplus: SKBI/20131204/S-3_1/4_EX-23.1/000.htm SEC Original: v355137_ex23-1.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to




Webplus: SKBI/20131204/S-3_1/5_EX-23.2/000.htm SEC Original: v355137_ex23-2.htm
Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended



Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: S-3, Date: 2013-12-04CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE

Home Page Forums

By | 2016-03-01T03:52:10+00:00 December 4th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar